3 Minute Read
The gross-to-net process, essential for understanding net revenue, demands a keen awareness of every piece of data and business drivers upstream. In this blog, we'll explore the critical considerations...
9 Minute Read
Discover the latest on the New Medicare Part D Agreement, 2024 Pharma Industry Shake-Up andth 2023 SPTR Recap updates this month.
3 Minute Read
Learn about this transformative period which poses both challenges and opportunities, urging stakeholders to adapt and innovate.
6 Minute Read
For the majority of life science and biotech companies, January is a time of closing the books, wrapping up year end results, and preparing for the annual audit. This...
4 Minute Read
Discover the latest on Medicare Part D, IRA Guidance, and 340B updates this month.
3 Minute Read
Learn about the updates for Assignment of Benefit Confusion for Pharma Manufacturers and CMS Eliminates Retroactive DIR Fees.
5 Minute Read
Learn about the updates for Medicaid Drug Rebate Program Proposed Rules, PBMs, Opportunities and Complexities.
4 Minute Read
In the pharmaceutical and biotech sector, "gross-to-net" (GTN) now goes beyond managing manufacturer discounts. It covers revenue management, reporting, and analytics. The Revenue Analytics Collaborative (RAC) started surveying members...
4 Minute Read
Updates on the Inflation Reduction Act.